Literature DB >> 26219435

Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II.

Hadrien Charvat1, Shizuka Sasazuki1, Manami Inoue1,2, Motoki Iwasaki1, Norie Sawada1, Taichi Shimazu1, Taiki Yamaji1, Shoichiro Tsugane1.   

Abstract

Gastric cancer is a particularly important issue in Japan, where incidence rates are among the highest observed. In this work, we provide a risk prediction model allowing the estimation of the 10-year cumulative probability of gastric cancer occurrence. The study population consisted of 19,028 individuals from the Japanese Public Health Center cohort II who were followed-up from 1993 to 2009. A parametric survival model was used to assess the impact on the probability of gastric cancer of clinical and lifestyle-related risk factors in combination with serum anti-Helicobacter pylori antibody titres and pepsinogen I and pepsinogen II levels. Based on the resulting model, cumulative probability estimates were calculated and a simple risk scoring system was developed. A total of 412 cases of gastric cancer occurred during 270,854 person-years of follow-up. The final model included (besides the biological markers) age, gender, smoking status, family history of gastric cancer and consumption of highly salted food. The developed prediction model showed good predictive performance in terms of discrimination (optimism-corrected c-index: 0.768) and calibration (Nam and d'Agostino's χ(2) test: 14.78; p values = 0.06). Estimates of the 10-year probability of gastric cancer occurrence ranged from 0.04% (0.02, 0.1) to 14.87% (8.96, 24.14) for men and from 0.03% (0.02, 0.07) to 4.91% (2.71, 8.81) for women. In conclusion, we developed a risk prediction model for gastric cancer that combines clinical and biological markers. It might prompt individuals to modify their lifestyle habits, attend regular check-up visits or participate in screening programmes.
© 2015 UICC.

Entities:  

Keywords:  Helicobacter pylori; gastric cancer; pepsinogen; prediction model

Mesh:

Year:  2015        PMID: 26219435     DOI: 10.1002/ijc.29705

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  40 in total

1.  Development and validation of a risk assessment tool for gastric cancer in a general Japanese population.

Authors:  Masahiro Iida; Fumie Ikeda; Jun Hata; Yoichiro Hirakawa; Tomoyuki Ohara; Naoko Mukai; Daigo Yoshida; Koji Yonemoto; Motohiro Esaki; Takanari Kitazono; Yutaka Kiyohara; Toshiharu Ninomiya
Journal:  Gastric Cancer       Date:  2017-10-17       Impact factor: 7.370

2.  Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR/AKT and VEGF signal pathways.

Authors:  Daye Zhang; Yongxiang Zhang; Zeyuan Cai; Ying Tu; Zhansong Hu
Journal:  Exp Ther Med       Date:  2019-11-21       Impact factor: 2.447

3.  Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer.

Authors:  Meira Epplein; Wei-Cheng You; Julia Butt; Yang Zhang; Laura H Hendrix; Christian C Abnet; Gwen Murphy; Wei Zheng; Xiao-Ou Shu; Shoichiro Tsugane; You-Lin Qiao; Philip R Taylor; Taichi Shimazu; Keun-Young Yoo; Sue K Park; Jeongseon Kim; Sun Ha Jee; Tim Waterboer; Michael Pawlita; Kai-Feng Pan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-08-29       Impact factor: 4.254

4.  Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study.

Authors:  Mayo Hirabayashi; Manami Inoue; Norie Sawada; Eiko Saito; Sarah K Abe; Akihisa Hidaka; Motoki Iwasaki; Taiki Yamaji; Taichi Shimazu; Shoichiro Tsugane
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

5.  Classifying risk level of gastric cancer: Evaluation of questionnaire-based prediction model.

Authors:  Maomao Cao; He Li; Dianqin Sun; Lin Lei; Jiansong Ren; Jufang Shi; Ni Li; Ji Peng; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2020-10-31       Impact factor: 5.087

6.  Sugary drink consumption and the subsequent risk of gastric cancer: The Japan Public Health Center-based Prospective Study.

Authors:  Paramita Khairan; Tomotaka Sobue; Ehab Salah Eshak; Tetsuhisa Kitamura; Motoki Iwasaki; Manami Inoue; Taiki Yamaji; Hiroyasu Iso; Shoichiro Tsugane; Norie Sawada
Journal:  Eur J Clin Nutr       Date:  2022-09-27       Impact factor: 4.884

7.  Usefulness of esophagogastroduodenoscopy and 18F-fluorodeoxyglucose positron-emission tomography in detecting synchronous multiple primary cancers with oral cancer.

Authors:  Naomi Ishibashi-Kanno; Kenji Yamagata; Fumihiko Uchida; Shogo Hasegawa; Toru Yanagawa; Hiroki Bukawa
Journal:  Oral Maxillofac Surg       Date:  2017-08-31

8.  Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population.

Authors:  Minkyo Song; M Constanza Camargo; Stephanie J Weinstein; Ana F Best; Satu Männistö; Demetrius Albanes; Charles S Rabkin
Journal:  Gastric Cancer       Date:  2018-02-17       Impact factor: 7.370

9.  Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.

Authors:  M Song; M C Camargo; S J Weinstein; G Murphy; N D Freedman; J Koshiol; R Z Stolzenberg-Solomon; C C Abnet; S Männistö; D Albanes; C S Rabkin
Journal:  Aliment Pharmacol Ther       Date:  2017-12-15       Impact factor: 8.171

Review 10.  Burden of Gastric Cancer.

Authors:  Aaron P Thrift; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-27       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.